Transcriptional regulatory functions of nuclear long noncoding RNAs.

Vance KW, Ponting CP. · 2014

Read Transcriptional regulatory functions of nuclear long noncoding RNAs. by Vance KW, Ponting CP. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4115187.txt.

Introduction

Keith W. Vance and Chris P. Ponting reviewed how long noncoding RNAs in the cell nucleus regulate gene transcription. Their review appeared in Trends in Genetics in 2014. More than ten thousand such RNAs, which carry no protein recipe, have been catalogued in mammals, most at low levels and in narrow tissue patterns.

A small number have proven jobs; the rest remain mysterious because function cannot yet be read from sequence. Known cases act nearby, shaping how enhancers reach promoters at their own site, or travel to distant genes across chromosomes. RNA-protein-DNA and RNA-DNA contacts guide them to their targets. The authors draw together recent studies of these mechanisms, framing nuclear long noncoding RNAs as genuine, targeted regulators rather than noise.

Catalog record

CREATORVance KW, Ponting CP.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4115187

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Transcriptional regulatory functions of nuclear long noncoding RNAs By Keith W. Vance, Chris P. Ponting Published in: Trends in Genetics DOI: 10.1016/j.tig.2014.06.001 ABSTRACT Highlights •Nuclear localised lncRNAs regulate the expression of both local and distal genes.•lncRNAs can function locally to regulate enhancer–promoter interactions.•lncRNAs can interact with chromatin at many different locations genome wide.•RNA–protein–DNA and RNA–DNA interactions guide lncRNAs to their target sites. EMERGING ROLES FOR NUCLEAR LNCRNAS The mammalian genome contains large numbers of noncoding RNA (ncRNA) loci that interdigitate between, within, and among protein-coding genes on either strand. To date, more than 10 000 mammalian intergenic lncRNAs [>200 nucleotides (nt)] (see Glossary) have been catalogued; the majority of these are expressed at lower levels compared with protein-coding transcripts, and are more tissue specific [1–3]. A small number of intergenic lncRNAs have been implicated in a variety of biological processes [4]. The functions, if any, of the remaining transcripts remain unknown and, in contrast to protein-coding sequence, cannot yet be predicted from sequence alone [5]. Some intergenic lncRNAs function as transcriptional regulators that can act locally, near their sites of synthesis, to regulate the expression of nearby genes, or distally to regulate gene expression across multiple chromosomes (Figure 1). Here, we draw upon recent studies to review the functions of nuclear localised intergenic lncRNAs in regulating gene transcription and chromatin organisation, their local and distal modes of action, their mechanisms of genomic targeting, and the nature of their interactions with chromatin. LNCRNAS FUNCTION AT THEIR SITES OF SYNTHESIS TO REGULATE LOCAL GENE EXPRESSION Intergenic lncRNAs have been divided, on the basis of chromatin marks at their promoters, into two broad categories: those emanating from enhancer regions or those transcribed from promoter-like lncRNA loci [6]. Most, if not all, transcriptional enhancer elements are transcribed to produce often exosome sensitive, unspliced transcripts termed ‘enhancer RNAs’ (eRNAs). The level of these transcripts tends to correlate positively with expression levels of neighbouring protein coding genes [7,8]. A subset of enhancers also appears to be associated with polyadenylated, more stable, and often spliced lncRNAs variously called elncRNAs, 1d-eRNAs, or ncRNA-activating lncRNAs (ncRNA-a) [6,9–11]. All of these transcripts are likely generated bidirectionally with RNAs transcribed from either or both strands being rapidly degraded, as seen for unstable antisense promoter upstream transcripts (PROMPTS) [12] and for intragenic enhancer produced transcripts [13]. Thus, further experiments will be needed to determine the relative proportions and functions of enhancer-associated lncRNA loci that are uni- or bi-directional, capped, and polyadenylated or unpolyadenylated, and multi- or mono-exonic. It is currently unknown whether eRNAs or elncRNAs are commonly simply a by-product of or an actual cause of enhancer action on neighbouring protein-coding genes. However, a small but growing number of eRNAs and elncRNAs have been shown to function at their site of synthesis in a RNA-dependent manner to regulate positively the expression of neighbouring protein coding genes on the same chromosome [14–18]. In one study, multiple 17B-oestradiol (E2)-induced eRNA transcripts were found to interact with cohesin in vitro and to induce looping interactions between their enhancer elements and the promoters of nearby target genes [15]. In another, two elncRNAs (ncRNA-a3 and ncRNA-a7) bound to components of the Mediator complex and also promoted enhancer–promoter looping interactions to regulate local gene expression [19]. In a third study, upon depletion of an eRNA transcribed from the MyoD1 core enhancer region, both MyoD1 chromatin accessibility and RNA polymerase II (PolII) occupancy were reduced and MyoD1 expression was decreased [17]. Therefore, enhancer-associated transcripts can modulate enhancer activity by altering local chromatin accessibility and/or structure. Nevertheless, other studies showed that eRNAs generated from p53-bound enhancers acted on pre-existing chromatin conformations to increase enhancer activity by unknown mechanisms [16] and that inhibition of eRNA production at estrogen receptor (ER) bound enhancers, for example by blocking transcriptional elongation, had no effect on chromatin looping yet still inhibited target gene activation [18]. Thus, enhancer-associated lncRNAs may have multiple RNA-dependent mechanisms of transcriptional control. lncRNA loci have also been ascribed RNA-independent functions in gene activation, for example that arise from transcription through loci affecting local chromatin accessibility, as described during fbp1+ gene activation in yeast [20]. In another example, the activity of the human growth hormone (hGH) HS1 enhancer was shown to be stimulated by lncRNA transcription that initiates immediately downstream of HS1 and is noncontiguous with the hGH target promoter [21]. To investigate the molecular mechanism of this stimulation, a transcriptional terminator was inserted into the locus, which led to reduced lncRNA transcription, and to a concomitant decrease in hGH expression. When the sequence of this lncRNA was replaced by that of an unrelated bacteriophage RNA, the enhancing effect of the natural transcript was recapitulated. Taken together, these studies show that enhancer-associated lncRNAs can also act locally, near their site of synthesis, using either RNA-dependent or -independent mechanisms to increase the transcriptional activity of chromosomally proximal protein coding genes. Local changes in gene expression are presumed to be mediated by cis-acting lncRNA modes of action on the same chromosome, and in an allele-specific manner. However, trans-acting lncRNA mechanisms could also operate to control nearby gene expression. The lncRNA Jpx, for example, is transcribed from the active X chromosome and can upregulate expression of the adjacent Xist gene on the other future inactive X allele in trans during the process of X chromosome inactivation [22]. Evf-2, in addition, modulates the activity of an enhancer element present within its locus by binding distal-less homeobox 2 (DLX2) and methyl CpG binding protein 2 (MECP2) and inhibiting DNA methylation of this enhancer to control expression of the genomically adjacent Dlx6 gene [23,24]. These effects occur in trans because Evf-2 and DLX2 cooperate to increase the activity of the Dlx6 enhancer when they are co-expressed from transiently transfected plasmids in a reporter assay, and Evf-2 inhibits DNA methylation when expressed ectopically from a transgene in a mouse model. In general, further mechanistic studies will be needed to assess the relative contributions of cis- and trans-acting lncRNA mechanisms controlling local gene expression. LNCRNAS WITH DISTAL REGULATORY FUNCTIONS Many experiments thus far have focussed on the possible mechanisms by which an enhancer-associated lncRNA or transcription of its locus regulates the expression level of an adjacent protein-coding gene. However, long-range intra-chromosomal interactions between eRNA expressing loci and distantly located loci have also been documented [15,16]. The TFF1 and NRIP1 eRNA containing loci, located 27 Mb apart on chromosome 21, are brought into close spatial proximity by long-range DNA looping interactions. This looping is induced by E2 and appears to be dependent on the NRIP1 eRNA. Therefore, a subset of eRNAs may have so far uncharacterised distal regulatory roles. What has been studied less often is whether lncRNA transcripts can function in trans at distal genomic locations. To address this and other issues, several techniques have been recently developed [25–28] to map the occupancy of lncRNAs genome-wide (Box 1). Although these approaches are providing insights into the direct or indirect binding of RNAs to genomic locations, it is important also to understand their limitations. One of these is that false positive inferences can arise from the direct DNA binding of the antisense oligonucleotides used to capture the RNA and also from the cross-linking of spatially adjacent genomic regions in the nucleus.

Read the complete text